TrialThe Journal of clinical endocrinology and metabolism2012

Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.

Elizabeth Shane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.